A 63-year-old white woman presented with a 12-month history of progressive tremor, unsteadiness and jerks of limbs. She was diagnosed with coeliac disease by biopsy 30 years previously. This was refractory in nature with intermittent diarrhoea and significant weight loss. She also had late onset complex partial seizures diagnosed 4 years previously, pernicious anaemia and osteoarthritis. Her medication included low dose steroids, carbamazepine 700 mg daily, vitamin B12 and folate. On examination she scored 30/30 on MMSE. She had myoclonus, tremor and ataxia. The myoclonus and tremor were worse in the upper limbs, present at rest, action and on sustained postures and were made worse with activity. The ataxia was predominantly in the limbs and was bilateral. She also had peri-oral tremulous movements. Cranial nerves, sensory examination, reflexes and the rest of the neurological examination were normal.
Case summary
A 63-year-old white woman presented with a 12-month history of progressive tremor, unsteadiness and jerks of limbs. She was diagnosed with coeliac disease by biopsy 30 years previously. This was refractory in nature with intermittent diarrhoea and significant weight loss. She also had late onset complex partial seizures diagnosed 4 years previously, pernicious anaemia and osteoarthritis. Her medication included low dose steroids, carbamazepine 700 mg daily, vitamin B12 and folate. On examination she scored 30/30 on MMSE. She had myoclonus, tremor and ataxia. The myoclonus and tremor were worse in the upper limbs, present at rest, action and on sustained postures and were made worse with activity. The ataxia was predominantly in the limbs and was bilateral. She also had peri-oral tremulous movements. Cranial nerves, sensory examination, reflexes and the rest of the neurological examination were normal.
Blood tests showed low albumin and calcium, raised alkaline phosphatase and AST. She had weakly positive ANA (titre 1/40). Vitamin B12, folate, serum lactate, caeruloplasmin were within normal limits. Antibodies to ANA and ENA and thyroid peroxidase were negative. Antiendomysial IgA and antigliadin were negative.
Onconeural antibodies including anti-Hu, anti-Yo, anti-Ri, anti-Tr, anti-amphiphysin, and those against voltage gated calcium and potassium channels were negative. Genetic tests for Huntington's disease, mitochondrial disorders (including MELAS mutation 3243, MERRF mutation 8345, NARP mutation 8993 and common duplications and deletions) were negative. CSF analysis showed 4 white cells, with normal protein and glucose. Oligoclonal bands were present. CT head, CT abdomen and chest X-ray were normal. As she was claustrophobic MRI could not be done after onset of tremor and ataxia. But an MRI done 4 years earlier (when seizures began) showed nonspecific ischemic changes in cerebral hemispheres and subtle early vermian and bilateral cerebellar hemispheric atrophy was suspected.
Carotid Doppler and 24 h ECGs were normal. EEG showed right anterior and mid temporal spike and waves and bilateral slow waves and sharp waves. Some of these spike waves discharges were associated with focal jerks of left arm and leg; there were no periodic complexes. Tibial somatosensory evoked potentials showed giant SEPs (Fig. 1) .
Many medications were tried over the subsequent 2 years to control the myoclonus but were poorly tolerated. Sodium valproate caused encephalopathy; clobazam was associated with drowsiness, lamotrigine with rash and zonisamide caused confusion. Levetiracetam was well tolerated however this did not control the myoclonus effectively. She was seen by gastroenterologists and in attempts to control the coeliac disease the Population-based screening studies suggest an overall prevalence of coeliac disease in Western populations of about 1%. A variety of neurological problems have been associated with coeliac disease occurring in up to 10% of cases of adult coeliac disease. We report an interesting case of a patient with coeliac disease who subsequently developed neurological symptoms several years later. Furthermore, a literature review of all cases to date was performed.
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prednisone dose was increased to 60 mg once daily on alternate days, along with azathioprine 100 mg daily. Over the next 2 years, she developed progressive cognitive problems along with deterioration in mobility and disabling myoclonus requiring 24-h care. She died following a cardio-respiratory arrest at home 6 years after the onset of neurologic symptoms and 33 years after the diagnosis of coeliac disease.
Discussion
We believe that the patient had refractory coeliac disease which is linked to her progressive neurological condition. Though causality is still not proven, several strands of evidence (immunological, histological and treatment response) support this concept including several similar reports.
Coeliac disease, gluten ataxia and dermatitis herepetiformis are the three gluten related autoimmune disorders. 1 Coeliac disease is characterized by malabsorption, structural abnormalities of small bowel mucosa such as villous atrophy, crypt hyperplasia and inflammation, and intolerance to gluten protein. In 1966, Cooke and Smith reported 16 patients with neurological complications of coeliac disease. 2 A variety of neurological problems have been associated with coeliac disease occurring in up to 10% of cases of adult coeliac disease. 3 These include peripheral neuropathy, myelopathy, encephalopathy and cerebellar ataxia. 2, 3 In 1980 the first case of progressive myoclonic ataxia syndrome and coeliac disease was reported. 3 At first this was thought to be a chance association as coeliac disease is common in the Caucasian population affecting 1 in 100 people. 4 However, further cases were reported and they are summarized below. A literature search for cases with progressive myoclonus and ataxia associated with coeliac disease was performed through medline with search terms 'coeliac' and 'myoclonus' and 'ataxia' identifying 15 cases in total (Table 1) . Our patient too had a characteristic phenotype dominated by action myoclonus and ataxia. As in some of the previous cases, electrophysiological assessment revealed a cortical origin for the myoclonus. Our patient had a biopsy diagnosis of coeliac disease, but antiendomysial and antigliadin antibody were negative. Four previous cases have also been antibody negative. The prevalence of seronegative coeliac disease is 6.4-9.1% of all diagnosed cases. 15 These patients tend to be older and have more severe disease. 16 Ataxia can also occur in the absence of coeliac disease. Gluten ataxia was originally defined as otherwise idiopathic sporadic ataxia with positive serological markers for gluten sensitization. 17 It is an auto-immune disease where damage to the cerebellum leads to ataxia. Recent studies have shown patients with gluten ataxia have deposits of anti-tissue transglutamase (anti-TTG) antibodies on brain vessels supporting the hypothesis that anti-TTG antibodies may affect the functioning of the blood-brain barrier.
Neurological disorders are only part of the wide spectrum of immunological conditions associated with coeliac. In one study 63 out of 314 patients (20%) with coeliac disease were found to have additional immunological disorders. 18 Autoimmune disease in general occurs more frequently in patients with coeliac disease compared with the normal population. These include autoimmune thyroid disease, type 1 diabetes mellitus, autoimmune liver diseases and inflammatory bowel disease. Prevalence of coeliac disease was noted to be 1-19% in patients with type 1 diabetes mellitus, 2-5% in autoimmune thyroid disorders and 3-7% in primary biliary cirrhosis in prospective studies. 19 Some reports have demonstrated an improvement in neurological complications with a gluten free diet. Hadjivassilou et al. studied 43 patients with ataxia caused by gluten sensitivity. After 1 year there was a significant improvement in ataxia in patients treated with a gluten-free diet compared to the control group. The diet associated improvement was apparent irrespective of the presence of an enteropathy. 20 Unfortunately, our patient did not improve with a gluten free diet. Immunosuppressant drugs have been tried but with inconclusive evidence. 18 Our patient was on prednisolone and azathioprine with no improvement in her neurological function.
In conclusion, we report a case of progressive neurological disorder in association with coeliac disease. We feel that the possibility of a gluten related disorder needs to be explored when unexplained neurological symptoms such as seizures, tremor, ataxia or myoclonus occur. In our case the epilepsy developed 26 years, and myoclonus and ataxia 29 years after the diagnosis of coeliac disease. Despite the lack of response to treatment, our patient and her family were grateful for an explanation for her condition.
